82467-2

LOINC 2.82

riTUXimab [Mass/volume] in Serum or Plasma by Immunoassay

riTUXimab SerPl IA-mCnc

Definition

  • This serum rituximab drug level is intended for quantitative measurements of rituximab levels in human serum to aid in patient-specific therapeutic drug monitoring and dosing for individuals with non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL) and rheumatoid arthritis.

Component

  • riTUXimab

Specimen / system

  • Ser/Plas

Class

  • DRUG/TOX

Property

  • MCnc

Scale

  • Qn

Method

  • IA

Related names

  • DRUG/TOXICOLOGY; Drugs; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; MabThera; Mass concentration; MEIA; Microscopic polyangiitis; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rituxan; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Wegener Granulomatosis; Zytux

Index terms

  • DRUG/TOXICOLOGY
  • Drugs
  • EIA
  • ELFA
  • ELISA
  • Enzyme immunoassay
  • IAA
  • Level
  • MabThera
  • Mass concentration
  • MEIA
  • Microscopic polyangiitis
  • Pl
  • Plasma
  • Plsm
  • Point in time
  • QNT
  • Quan
  • Quant
  • Quantitative
  • Random
  • Rituxan
  • SerP
  • SerPl
  • SerPlas
  • Serum
  • Serum or plasma
  • SR
  • SUDS
  • Wegener Granulomatosis
  • Zytux